Helwan University
Clinical trials sponsored by Helwan University, explained in plain language.
-
Heart shield: diabetes drug may protect breast cancer patients from chemo side effects
Disease control Recruiting nowThis study tests if dapagliflozin, a drug used for diabetes, can prevent heart damage caused by anthracycline chemotherapy in breast cancer patients. About 40 adults with breast cancer who are scheduled for anthracycline treatment will take dapagliflozin or a placebo. Researchers…
Phase: PHASE4 • Sponsor: Helwan University • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New combo sedation aims to protect elderly hearts in ICU
Symptom relief Recruiting nowThis study compares a combination of two sedatives (propofol and ketamine) against propofol alone in elderly ICU patients who need a breathing tube. The goal is to see if the combo reduces dangerous drops in blood pressure. The trial involves 41 patients aged 65 or older with hea…
Phase: PHASE3 • Sponsor: Helwan University • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
New bendable tool may make kidney stone removal safer and more effective
Symptom relief Recruiting nowThis study tests a new, bendable tube with suction against a standard tube for removing large kidney stones (staghorn stones) through a scope. About 100 adults with these stones will be randomly assigned to one of the two methods. The goal is to see which approach causes fewer co…
Phase: NA • Sponsor: Helwan University • Aim: Symptom relief
Last updated May 11, 2026 20:51 UTC